Bank Of America Corp Anebulo Pharmaceuticals, Inc. Transaction History
Bank Of America Corp
- $1.06 Trillion
- Q1 2024
Shares
1 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
7.31MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$14.3 Million15.16% of portfolio
-
Lvw Advisors, LLC642KShares$1.71 Million0.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$1.36 Million0.09% of portfolio
-
Morgan Stanley New York, NY399KShares$1.06 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$419,9120.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $68.2M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...